XML 30 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statement of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2018                   37,446,323                
Balance at Dec. 31, 2018                   $ 374 $ 267,317 $ (31,127) $ (3,989) $ (15) $ (1,543) $ 231,017 $ 45,356 $ 276,373
Issuance of common stock (in shares)                   115,421                
Issuance of common stock                   $ 1 514 0 0 0 0 515 0 515
Share-based compensation expenses                   0 425 0 0 0 0 425 0 425
Warrant expenses                   0 0 0 0 0 0 0 0 0
Net income (loss)                   0 0 (3,346) 0 0 0 (3,346) 189 (3,157)
Other comprehensive loss for the period                   $ 0 0 0 567 (65) 90 592 86 678
Balance (in shares) at Mar. 31, 2019                   37,561,744                
Balance at Mar. 31, 2019                   $ 375 268,256 (34,473) (3,422) (80) (1,453) 229,203 45,631 $ 274,834
Balance (in shares) at Dec. 31, 2019                   38,525,636               38,525,636
Balance at Dec. 31, 2019 $ 0 $ 413 $ (413) $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 385 276,827 (46,145) (4,568) 475 (1,929) 225,045 46,739 $ 271,784
Issuance of common stock (in shares)                   16,088                
Issuance of common stock                   $ 0 43 0 0 0 0 43 0 43
Share-based compensation expenses                   0 291 0 0 0 0 291 0 291
Warrant expenses                   0 278 0 0 0 0 278 0 278
Net income (loss)                   0 0 (26,557) 0 0 0 (26,557) 576 (25,981)
Other comprehensive loss for the period                   $ 0 0 0 (4,392) (672) 233 (4,831) 163 $ (4,668)
Balance (in shares) at Mar. 31, 2020                   38,541,724               38,541,724
Balance at Mar. 31, 2020                   $ 385 $ 277,852 $ (73,115) $ (8,960) $ (197) $ (1,696) $ 194,269 $ 47,478 $ 241,747